CLARISCAN 0.5 mmol/ml, solution for injection in a pre-filled syringe 10 syringes of 15 ml
Active ingredients: Gadoteric acid, Gadoterate meglumine
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 syringes of 15 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLARISCAN 0,5 mmol/mL, solution injectable en seringue pré-remplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 seringue(s) préremplie(s) polycyclooléfine de 15 ml
- Marketing authorisation holder
- GE HEALTHCARE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Nov 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63807217CIP73009185CIP133400930091852Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GADOTÉRATE DE MÉGLUMINEsolution | — | SA |
| ACIDE GADOTÉRIQUEsolution | 279,3 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.